

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.20553318 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.09887457 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.96886680 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63418023 |
| 5 | layer formation in cerebral cortex (GO:0021819) | 4.47733179 |
| 6 | vocalization behavior (GO:0071625) | 4.36562182 |
| 7 | glutamate secretion (GO:0014047) | 4.33418327 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.28042745 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.27168099 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.24078816 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.17750102 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.09970868 |
| 13 | regulation of synapse structural plasticity (GO:0051823) | 3.95278843 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.87599891 |
| 15 | proline transport (GO:0015824) | 3.81783778 |
| 16 | exploration behavior (GO:0035640) | 3.78788576 |
| 17 | activation of protein kinase A activity (GO:0034199) | 3.70231245 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 3.64590366 |
| 19 | dendritic spine morphogenesis (GO:0060997) | 3.61339160 |
| 20 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.56468803 |
| 21 | protein localization to synapse (GO:0035418) | 3.53717291 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.51407535 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.50148160 |
| 24 | neurotransmitter secretion (GO:0007269) | 3.48199332 |
| 25 | sodium ion export (GO:0071436) | 3.34046687 |
| 26 | positive regulation of neurotransmitter transport (GO:0051590) | 3.33588450 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31545308 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 3.30782158 |
| 29 | dendrite morphogenesis (GO:0048813) | 3.28071915 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.19687078 |
| 31 | cell communication by electrical coupling (GO:0010644) | 3.15762701 |
| 32 | neuron cell-cell adhesion (GO:0007158) | 3.15364473 |
| 33 | neuronal action potential propagation (GO:0019227) | 3.10251870 |
| 34 | neuromuscular process controlling balance (GO:0050885) | 3.08072579 |
| 35 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05857203 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.03167762 |
| 37 | neuron recognition (GO:0008038) | 3.03047811 |
| 38 | positive regulation of actin filament depolymerization (GO:0030836) | 3.03015221 |
| 39 | regulation of ARF protein signal transduction (GO:0032012) | 3.02732225 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.00301285 |
| 41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.99027874 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 2.98715506 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.96038954 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.94203744 |
| 45 | vesicle transport along microtubule (GO:0047496) | 2.92039605 |
| 46 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.87745033 |
| 47 | cerebellar Purkinje cell layer development (GO:0021680) | 2.87734494 |
| 48 | negative regulation of dendrite development (GO:2000171) | 2.85664128 |
| 49 | synaptic transmission, glutamatergic (GO:0035249) | 2.85559399 |
| 50 | long-term memory (GO:0007616) | 2.85533122 |
| 51 | righting reflex (GO:0060013) | 2.85023967 |
| 52 | axonal fasciculation (GO:0007413) | 2.83013772 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.81246273 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 2.77596673 |
| 55 | regulation of neurotransmitter transport (GO:0051588) | 2.77396200 |
| 56 | alanine transport (GO:0032328) | 2.77294212 |
| 57 | potassium ion homeostasis (GO:0055075) | 2.77081436 |
| 58 | glutamate receptor signaling pathway (GO:0007215) | 2.76392746 |
| 59 | organelle transport along microtubule (GO:0072384) | 2.75921901 |
| 60 | positive regulation of membrane potential (GO:0045838) | 2.74934961 |
| 61 | plasma membrane repair (GO:0001778) | 2.73713630 |
| 62 | regulation of cell communication by electrical coupling (GO:0010649) | 2.73471828 |
| 63 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.72236175 |
| 64 | dendritic spine organization (GO:0097061) | 2.71889916 |
| 65 | postsynaptic membrane organization (GO:0001941) | 2.71373559 |
| 66 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71352269 |
| 67 | astrocyte differentiation (GO:0048708) | 2.68329209 |
| 68 | regulation of postsynaptic membrane potential (GO:0060078) | 2.67406741 |
| 69 | neurotransmitter transport (GO:0006836) | 2.66434929 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66037806 |
| 71 | clathrin coat assembly (GO:0048268) | 2.65731718 |
| 72 | synaptic vesicle endocytosis (GO:0048488) | 2.65161225 |
| 73 | positive regulation of protein autophosphorylation (GO:0031954) | 2.65135944 |
| 74 | cell communication involved in cardiac conduction (GO:0086065) | 2.64763382 |
| 75 | neuron-neuron synaptic transmission (GO:0007270) | 2.64660935 |
| 76 | cell migration in hindbrain (GO:0021535) | 2.64634436 |
| 77 | regulation of vesicle fusion (GO:0031338) | 2.63018016 |
| 78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62474086 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 2.61528884 |
| 80 | nerve growth factor signaling pathway (GO:0038180) | 2.59561150 |
| 81 | mating behavior (GO:0007617) | 2.59477162 |
| 82 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.55621192 |
| 83 | glycine transport (GO:0015816) | 2.55475401 |
| 84 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.55337895 |
| 85 | prepulse inhibition (GO:0060134) | 2.55219449 |
| 86 | axon extension (GO:0048675) | 2.54716319 |
| 87 | regulation of dendritic spine development (GO:0060998) | 2.54529995 |
| 88 | innervation (GO:0060384) | 2.54009360 |
| 89 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.52989083 |
| 90 | cerebellar granule cell differentiation (GO:0021707) | 2.52203918 |
| 91 | positive regulation of axon extension (GO:0045773) | 2.52001102 |
| 92 | regulation of Rac protein signal transduction (GO:0035020) | 2.51996031 |
| 93 | auditory behavior (GO:0031223) | 2.50961804 |
| 94 | positive regulation of fibroblast migration (GO:0010763) | 2.49194705 |
| 95 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.48936905 |
| 96 | neuromuscular synaptic transmission (GO:0007274) | 2.47714924 |
| 97 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.45864021 |
| 98 | regulation of neurotransmitter levels (GO:0001505) | 2.45165261 |
| 99 | calcium ion-dependent exocytosis (GO:0017156) | 2.44268464 |
| 100 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.43672179 |
| 101 | macroautophagy (GO:0016236) | 2.43017349 |
| 102 | insulin secretion (GO:0030073) | 2.42809939 |
| 103 | signal release (GO:0023061) | 2.41832362 |
| 104 | presynaptic membrane assembly (GO:0097105) | 2.41687353 |
| 105 | detection of calcium ion (GO:0005513) | 2.41481534 |
| 106 | membrane depolarization during action potential (GO:0086010) | 2.41344693 |
| 107 | long-term synaptic potentiation (GO:0060291) | 2.41221455 |
| 108 | positive regulation of dendritic spine development (GO:0060999) | 2.41122346 |
| 109 | inositol phosphate catabolic process (GO:0071545) | 2.41040658 |
| 110 | axon cargo transport (GO:0008088) | 2.40914291 |
| 111 | response to auditory stimulus (GO:0010996) | 2.40712800 |
| 112 | potassium ion import (GO:0010107) | 2.40615996 |
| 113 | neuronal ion channel clustering (GO:0045161) | 2.40465351 |
| 114 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.39246377 |
| 115 | membrane repolarization (GO:0086009) | 2.39129539 |
| 116 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.38882751 |
| 117 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.38779142 |
| 118 | synapse organization (GO:0050808) | 2.38367187 |
| 119 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.38335653 |
| 120 | establishment of nucleus localization (GO:0040023) | 2.37208348 |
| 121 | neuron projection extension (GO:1990138) | 2.37126280 |
| 122 | negative regulation of microtubule polymerization (GO:0031115) | 2.36194221 |
| 123 | neuromuscular process (GO:0050905) | 2.35998741 |
| 124 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.35836100 |
| 125 | membrane depolarization (GO:0051899) | 2.35314001 |
| 126 | transferrin transport (GO:0033572) | 2.34168039 |
| 127 | glycosphingolipid biosynthetic process (GO:0006688) | 2.33576617 |
| 128 | presynaptic membrane organization (GO:0097090) | 2.33506579 |
| 129 | melanin biosynthetic process (GO:0042438) | 2.33426463 |
| 130 | startle response (GO:0001964) | 2.32784869 |
| 131 | regulation of neurotransmitter uptake (GO:0051580) | 2.31748654 |
| 132 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.30580000 |
| 133 | ferric iron transport (GO:0015682) | 2.27774471 |
| 134 | trivalent inorganic cation transport (GO:0072512) | 2.27774471 |
| 135 | response to gravity (GO:0009629) | 2.27361204 |
| 136 | inositol phosphate-mediated signaling (GO:0048016) | 2.26268646 |
| 137 | establishment of synaptic vesicle localization (GO:0097480) | 2.25969975 |
| 138 | synaptic vesicle transport (GO:0048489) | 2.25969975 |
| 139 | synaptic transmission (GO:0007268) | 2.22380604 |
| 140 | chemosensory behavior (GO:0007635) | 2.22164342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.20257129 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.57983419 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.57174766 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.40579335 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35349021 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.35231646 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.35231646 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32395327 |
| 9 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31435296 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30154501 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.28610018 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27633976 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22425077 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19666913 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.18721192 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17262992 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14597402 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04385909 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.02576901 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.99889370 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99432627 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97019362 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93507263 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86046179 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80279900 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74904779 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73083528 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67893156 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67204098 |
| 30 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.60059399 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59378156 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.57829272 |
| 33 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53304258 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49862724 |
| 35 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48561047 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47072079 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46707029 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43175369 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41317756 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38500036 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.37075941 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.36737150 |
| 43 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35313963 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34764235 |
| 45 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34515781 |
| 46 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33174922 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32521044 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31535241 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31247293 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30926439 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30331327 |
| 52 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30215924 |
| 53 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.29862548 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25040326 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24016697 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23707832 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23010709 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22287818 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20249771 |
| 60 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19578272 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19045890 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18562262 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18111779 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16539077 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16258970 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15664719 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15522413 |
| 68 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14256741 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13911929 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12419411 |
| 71 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11971949 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11862497 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11833131 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11678384 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.11148778 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10178017 |
| 77 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10141925 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09768613 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08390595 |
| 80 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07518887 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06395113 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06074493 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04280585 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03858141 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03785001 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03559086 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02454412 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02190289 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01594094 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01211203 |
| 91 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00585878 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00473845 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00189948 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00172731 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99607686 |
| 96 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97466416 |
| 97 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96942806 |
| 98 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96810312 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96584387 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96502264 |
| 101 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95501403 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95270854 |
| 103 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95269825 |
| 104 | * JUN_21703547_ChIP-Seq_K562_Human | 0.95217217 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94855573 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94810193 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94627573 |
| 108 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94043349 |
| 109 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94025263 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93680855 |
| 111 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93289235 |
| 112 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93279741 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93106889 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92289088 |
| 115 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92060047 |
| 116 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91949196 |
| 117 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91371224 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91047643 |
| 119 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91023176 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90608076 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90531481 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88651783 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.88579541 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87242719 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86717316 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86682988 |
| 127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84824483 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84824483 |
| 129 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.84771391 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84541958 |
| 131 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83949102 |
| 132 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83828176 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83711209 |
| 134 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82947211 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82855985 |
| 136 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.82331998 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81850951 |
| 138 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81786972 |
| 139 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80530205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.22601428 |
| 2 | MP0004270_analgesia | 3.79606815 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.61914956 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 3.06648477 |
| 5 | MP0003880_abnormal_central_pattern | 3.04079584 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.95702039 |
| 7 | MP0009745_abnormal_behavioral_response | 2.65318524 |
| 8 | MP0004858_abnormal_nervous_system | 2.56143292 |
| 9 | MP0002064_seizures | 2.45338638 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.38829594 |
| 11 | MP0003329_amyloid_beta_deposits | 2.36672796 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.36045478 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.34876098 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.33723961 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.24793752 |
| 16 | MP0009046_muscle_twitch | 2.12848615 |
| 17 | MP0002822_catalepsy | 2.05370965 |
| 18 | MP0005423_abnormal_somatic_nervous | 1.97307183 |
| 19 | MP0003787_abnormal_imprinting | 1.97185438 |
| 20 | MP0001440_abnormal_grooming_behavior | 1.96277027 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.95887036 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.88498107 |
| 23 | MP0002638_abnormal_pupillary_reflex | 1.84602008 |
| 24 | MP0001486_abnormal_startle_reflex | 1.84526195 |
| 25 | MP0003283_abnormal_digestive_organ | 1.81017017 |
| 26 | MP0000751_myopathy | 1.80974445 |
| 27 | MP0002272_abnormal_nervous_system | 1.75105755 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.73904566 |
| 29 | MP0003879_abnormal_hair_cell | 1.71980620 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.67992604 |
| 31 | MP0002736_abnormal_nociception_after | 1.67932334 |
| 32 | MP0001970_abnormal_pain_threshold | 1.67507020 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.62466359 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.57508237 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.56384088 |
| 36 | MP0000778_abnormal_nervous_system | 1.55254454 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.51001909 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.50702062 |
| 39 | MP0002184_abnormal_innervation | 1.49044977 |
| 40 | MP0005171_absent_coat_pigmentation | 1.48343386 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.43026084 |
| 42 | MP0000604_amyloidosis | 1.42722871 |
| 43 | MP0008569_lethality_at_weaning | 1.39313390 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.39222157 |
| 45 | MP0004924_abnormal_behavior | 1.38721081 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.38721081 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.38590651 |
| 48 | MP0000955_abnormal_spinal_cord | 1.38174807 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.36838101 |
| 50 | MP0004885_abnormal_endolymph | 1.36129744 |
| 51 | MP0004130_abnormal_muscle_cell | 1.33371179 |
| 52 | MP0003633_abnormal_nervous_system | 1.26860299 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.23505826 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.23419018 |
| 55 | MP0004510_myositis | 1.22863630 |
| 56 | MP0003123_paternal_imprinting | 1.21966539 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.21075611 |
| 58 | MP0001905_abnormal_dopamine_level | 1.21040071 |
| 59 | MP0003075_altered_response_to | 1.19755198 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.18711181 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.13338071 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.12718150 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.11087955 |
| 64 | MP0000749_muscle_degeneration | 1.10055350 |
| 65 | MP0004043_abnormal_pH_regulation | 1.09990862 |
| 66 | MP0002102_abnormal_ear_morphology | 1.09549440 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.09399337 |
| 68 | MP0005535_abnormal_body_temperature | 1.05651661 |
| 69 | MP0002090_abnormal_vision | 1.04998517 |
| 70 | MP0000747_muscle_weakness | 1.04670162 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.03652427 |
| 72 | MP0003634_abnormal_glial_cell | 1.02598504 |
| 73 | MP0003631_nervous_system_phenotype | 1.00620131 |
| 74 | MP0001944_abnormal_pancreas_morphology | 1.00392202 |
| 75 | MP0001502_abnormal_circadian_rhythm | 0.97129874 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.96922808 |
| 77 | MP0005248_abnormal_Harderian_gland | 0.95636659 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.92316353 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.92092953 |
| 80 | MP0004233_abnormal_muscle_weight | 0.91763432 |
| 81 | MP0003303_peritoneal_inflammation | 0.91297662 |
| 82 | MP0004085_abnormal_heartbeat | 0.90476949 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.89786610 |
| 84 | MP0003690_abnormal_glial_cell | 0.88227023 |
| 85 | MP0005408_hypopigmentation | 0.88102140 |
| 86 | MP0004484_altered_response_of | 0.87966673 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.87398695 |
| 88 | MP0002152_abnormal_brain_morphology | 0.87129545 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.86037316 |
| 90 | MP0005187_abnormal_penis_morphology | 0.85755756 |
| 91 | MP0006054_spinal_hemorrhage | 0.84917399 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.82914866 |
| 93 | MP0001756_abnormal_urination | 0.82512759 |
| 94 | MP0008874_decreased_physiological_sensi | 0.82161056 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.81690422 |
| 96 | MP0001984_abnormal_olfaction | 0.81447478 |
| 97 | MP0003045_fibrosis | 0.81443686 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.81172057 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.80608638 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.80392117 |
| 101 | MP0005620_abnormal_muscle_contractility | 0.78205209 |
| 102 | MP0002938_white_spotting | 0.77152432 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.74387893 |
| 104 | MP0001348_abnormal_lacrimal_gland | 0.74368135 |
| 105 | MP0000538_abnormal_urinary_bladder | 0.74088703 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.73970500 |
| 107 | MP0004087_abnormal_muscle_fiber | 0.73966816 |
| 108 | MP0001177_atelectasis | 0.73391303 |
| 109 | MP0003632_abnormal_nervous_system | 0.72647499 |
| 110 | MP0008438_abnormal_cutaneous_collagen | 0.72574082 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.72269700 |
| 112 | MP0005253_abnormal_eye_physiology | 0.71301242 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.70923633 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.69925424 |
| 115 | MP0003195_calcinosis | 0.69911979 |
| 116 | MP0000920_abnormal_myelination | 0.69251863 |
| 117 | MP0002229_neurodegeneration | 0.68920238 |
| 118 | MP0003950_abnormal_plasma_membrane | 0.68532753 |
| 119 | MP0002972_abnormal_cardiac_muscle | 0.67526283 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.67104427 |
| 121 | MP0003868_abnormal_feces_composition | 0.66167670 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.65843687 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.64642713 |
| 124 | MP0005166_decreased_susceptibility_to | 0.64055315 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.61521429 |
| 126 | MP0002269_muscular_atrophy | 0.60942826 |
| 127 | MP0003122_maternal_imprinting | 0.60712692 |
| 128 | MP0003091_abnormal_cell_migration | 0.60706732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.17201278 |
| 2 | Focal motor seizures (HP:0011153) | 4.43893463 |
| 3 | Visual hallucinations (HP:0002367) | 4.28329861 |
| 4 | Focal seizures (HP:0007359) | 3.98838954 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 3.62758600 |
| 6 | Action tremor (HP:0002345) | 3.32978681 |
| 7 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.28444882 |
| 8 | Hypoplasia of the fovea (HP:0007750) | 3.28444882 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.24035825 |
| 10 | Ankle clonus (HP:0011448) | 3.09811652 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.01228660 |
| 12 | Epileptic encephalopathy (HP:0200134) | 2.95998066 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 2.95517250 |
| 14 | Papilledema (HP:0001085) | 2.93344901 |
| 15 | Poor eye contact (HP:0000817) | 2.88313127 |
| 16 | Absence seizures (HP:0002121) | 2.88312545 |
| 17 | Atonic seizures (HP:0010819) | 2.87891744 |
| 18 | Impaired social interactions (HP:0000735) | 2.81986942 |
| 19 | Abnormal social behavior (HP:0012433) | 2.81986942 |
| 20 | Mutism (HP:0002300) | 2.81065517 |
| 21 | Abnormality of the lower motor neuron (HP:0002366) | 2.72097672 |
| 22 | Depression (HP:0000716) | 2.69506198 |
| 23 | Abnormality of the fovea (HP:0000493) | 2.59966536 |
| 24 | Insidious onset (HP:0003587) | 2.57938597 |
| 25 | Termporal pattern (HP:0011008) | 2.57938597 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 2.52778357 |
| 27 | Urinary urgency (HP:0000012) | 2.52032226 |
| 28 | Dialeptic seizures (HP:0011146) | 2.51697132 |
| 29 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.49299329 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.49262163 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.46974048 |
| 32 | Postural instability (HP:0002172) | 2.46436143 |
| 33 | Torticollis (HP:0000473) | 2.44409740 |
| 34 | Rapidly progressive (HP:0003678) | 2.37698426 |
| 35 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.36866337 |
| 36 | Lower limb amyotrophy (HP:0007210) | 2.35845895 |
| 37 | Diminished movement (HP:0002374) | 2.35793242 |
| 38 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.32510529 |
| 39 | Bundle branch block (HP:0011710) | 2.32254779 |
| 40 | Anxiety (HP:0000739) | 2.31876881 |
| 41 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31758560 |
| 42 | Resting tremor (HP:0002322) | 2.30644678 |
| 43 | Megalencephaly (HP:0001355) | 2.29208065 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.28119142 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.27919156 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.25731124 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.25731124 |
| 48 | Febrile seizures (HP:0002373) | 2.25414872 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.25301408 |
| 50 | Hamartoma of the eye (HP:0010568) | 2.25268306 |
| 51 | Dysdiadochokinesis (HP:0002075) | 2.24548471 |
| 52 | Agitation (HP:0000713) | 2.24211590 |
| 53 | Pheochromocytoma (HP:0002666) | 2.23413330 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22479684 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22479684 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22479684 |
| 57 | Amblyopia (HP:0000646) | 2.21582035 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19316756 |
| 59 | Ocular albinism (HP:0001107) | 2.17680683 |
| 60 | Hypsarrhythmia (HP:0002521) | 2.17348918 |
| 61 | Heterochromia iridis (HP:0001100) | 2.17295422 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.17152460 |
| 63 | Hypokinesia (HP:0002375) | 2.15660350 |
| 64 | Focal dystonia (HP:0004373) | 2.12249353 |
| 65 | Dysmetria (HP:0001310) | 2.11973333 |
| 66 | Sudden death (HP:0001699) | 2.11782317 |
| 67 | Tetraplegia (HP:0002445) | 2.11298213 |
| 68 | Blue irides (HP:0000635) | 2.10875972 |
| 69 | Tongue fasciculations (HP:0001308) | 2.09156346 |
| 70 | Apathy (HP:0000741) | 2.09061634 |
| 71 | Broad-based gait (HP:0002136) | 2.08518137 |
| 72 | Iris hypopigmentation (HP:0007730) | 2.08190611 |
| 73 | Intention tremor (HP:0002080) | 2.08004375 |
| 74 | Achilles tendon contracture (HP:0001771) | 2.06498925 |
| 75 | Hypothermia (HP:0002045) | 2.06308732 |
| 76 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02953057 |
| 77 | Delayed gross motor development (HP:0002194) | 2.02764213 |
| 78 | Akinesia (HP:0002304) | 2.02401726 |
| 79 | Ketoacidosis (HP:0001993) | 2.02369951 |
| 80 | Drooling (HP:0002307) | 2.02010343 |
| 81 | Excessive salivation (HP:0003781) | 2.02010343 |
| 82 | Hypoglycemic coma (HP:0001325) | 2.01868365 |
| 83 | Hyperglycemia (HP:0003074) | 2.01596875 |
| 84 | Truncal ataxia (HP:0002078) | 2.01256343 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 2.00834197 |
| 86 | Delusions (HP:0000746) | 1.99682662 |
| 87 | Hyporeflexia of lower limbs (HP:0002600) | 1.97539875 |
| 88 | Calf muscle hypertrophy (HP:0008981) | 1.97421137 |
| 89 | Craniofacial dystonia (HP:0012179) | 1.96955462 |
| 90 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96942217 |
| 91 | Lower limb muscle weakness (HP:0007340) | 1.96683279 |
| 92 | Congenital glaucoma (HP:0001087) | 1.96628835 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.96306885 |
| 94 | Muscular hypotonia of the trunk (HP:0008936) | 1.96117698 |
| 95 | Dysmetric saccades (HP:0000641) | 1.95904949 |
| 96 | Hand muscle atrophy (HP:0009130) | 1.95821668 |
| 97 | Exercise-induced myalgia (HP:0003738) | 1.95002324 |
| 98 | Bradykinesia (HP:0002067) | 1.94885814 |
| 99 | Hypercortisolism (HP:0001578) | 1.94416128 |
| 100 | Gaze-evoked nystagmus (HP:0000640) | 1.94347356 |
| 101 | Spastic gait (HP:0002064) | 1.93142137 |
| 102 | Hemiplegia (HP:0002301) | 1.90509456 |
| 103 | Genetic anticipation (HP:0003743) | 1.89956919 |
| 104 | Spastic tetraparesis (HP:0001285) | 1.89583977 |
| 105 | Abnormality of the corticospinal tract (HP:0002492) | 1.89566013 |
| 106 | Fetal akinesia sequence (HP:0001989) | 1.89215352 |
| 107 | Diminished motivation (HP:0000745) | 1.88466357 |
| 108 | Bronchomalacia (HP:0002780) | 1.87786505 |
| 109 | Stereotypic behavior (HP:0000733) | 1.87497939 |
| 110 | Enlarged penis (HP:0000040) | 1.87369249 |
| 111 | Obstructive sleep apnea (HP:0002870) | 1.86189029 |
| 112 | Diplopia (HP:0000651) | 1.84563399 |
| 113 | Abnormality of binocular vision (HP:0011514) | 1.84563399 |
| 114 | Hyperventilation (HP:0002883) | 1.84504722 |
| 115 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.83633950 |
| 116 | Insomnia (HP:0100785) | 1.83575384 |
| 117 | Hemiparesis (HP:0001269) | 1.82855712 |
| 118 | Frequent falls (HP:0002359) | 1.82823890 |
| 119 | Lower limb asymmetry (HP:0100559) | 1.82666033 |
| 120 | Postural tremor (HP:0002174) | 1.82559988 |
| 121 | Generalized myoclonic seizures (HP:0002123) | 1.81866960 |
| 122 | Absent speech (HP:0001344) | 1.81074520 |
| 123 | Status epilepticus (HP:0002133) | 1.80967451 |
| 124 | Neuroendocrine neoplasm (HP:0100634) | 1.79651191 |
| 125 | Syncope (HP:0001279) | 1.79099538 |
| 126 | Inappropriate behavior (HP:0000719) | 1.78986384 |
| 127 | Hydroxyprolinuria (HP:0003080) | 1.78799110 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.78799110 |
| 129 | Increased cerebral lipofuscin (HP:0011813) | 1.78383138 |
| 130 | Difficulty running (HP:0009046) | 1.78059168 |
| 131 | Turricephaly (HP:0000262) | 1.77938461 |
| 132 | Macroorchidism (HP:0000053) | 1.77412319 |
| 133 | Clonus (HP:0002169) | 1.76979699 |
| 134 | Lymphangioma (HP:0100764) | 1.76861783 |
| 135 | Cardiovascular calcification (HP:0011915) | 1.76223695 |
| 136 | Limb dystonia (HP:0002451) | 1.75695106 |
| 137 | Hypoventilation (HP:0002791) | 1.75489887 |
| 138 | Mitral stenosis (HP:0001718) | 1.75457921 |
| 139 | Muscle fibrillation (HP:0010546) | 1.75172429 |
| 140 | Prolonged QT interval (HP:0001657) | 1.75016883 |
| 141 | Polyphagia (HP:0002591) | 1.74454731 |
| 142 | Buphthalmos (HP:0000557) | 1.74448324 |
| 143 | Global brain atrophy (HP:0002283) | 1.73849115 |
| 144 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.73829535 |
| 145 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73513422 |
| 146 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73513422 |
| 147 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73513422 |
| 148 | Conjunctival hamartoma (HP:0100780) | 1.73250737 |
| 149 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71330903 |
| 150 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.71097202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.81552778 |
| 2 | MARK1 | 3.73586843 |
| 3 | NTRK3 | 3.27645209 |
| 4 | EPHA4 | 3.18554697 |
| 5 | DAPK2 | 2.77221012 |
| 6 | CASK | 2.69150375 |
| 7 | KSR2 | 2.55977341 |
| 8 | PRKD3 | 2.46749895 |
| 9 | MINK1 | 2.30649854 |
| 10 | PAK6 | 2.29343207 |
| 11 | TRIM28 | 2.26222114 |
| 12 | NTRK1 | 2.21942848 |
| 13 | TRIB3 | 2.21515716 |
| 14 | MAP3K4 | 2.18792622 |
| 15 | CAMKK1 | 2.03812177 |
| 16 | MAP3K2 | 1.91876671 |
| 17 | PHKG1 | 1.67044383 |
| 18 | PHKG2 | 1.67044383 |
| 19 | RIPK1 | 1.64565521 |
| 20 | MAP2K4 | 1.62662874 |
| 21 | LATS2 | 1.52190670 |
| 22 | SIK3 | 1.50982430 |
| 23 | NTRK2 | 1.50600988 |
| 24 | KSR1 | 1.50509834 |
| 25 | BMPR1B | 1.44136737 |
| 26 | RIPK4 | 1.43116798 |
| 27 | CDK5 | 1.41778906 |
| 28 | PKN2 | 1.38516011 |
| 29 | ACVR1B | 1.37307588 |
| 30 | SIK2 | 1.36246751 |
| 31 | RET | 1.33057334 |
| 32 | MAP2K7 | 1.31049084 |
| 33 | TYRO3 | 1.29656193 |
| 34 | TAOK1 | 1.29365811 |
| 35 | PAK3 | 1.25361506 |
| 36 | BCR | 1.23098679 |
| 37 | TESK1 | 1.22338279 |
| 38 | SCYL2 | 1.20688421 |
| 39 | STK38 | 1.12862783 |
| 40 | DAPK1 | 1.12011115 |
| 41 | PDGFRA | 1.09113905 |
| 42 | GRK5 | 1.06345909 |
| 43 | CAMKK2 | 1.05096726 |
| 44 | FGFR2 | 1.03188663 |
| 45 | PLK2 | 1.00512207 |
| 46 | PRKCH | 0.99375989 |
| 47 | CAMK2D | 0.98796782 |
| 48 | LMTK2 | 0.94994304 |
| 49 | STK11 | 0.92088526 |
| 50 | MAP3K1 | 0.91663789 |
| 51 | ALK | 0.88849065 |
| 52 | STK39 | 0.88169387 |
| 53 | EIF2AK1 | 0.86577737 |
| 54 | PRKCG | 0.86118210 |
| 55 | MAP3K12 | 0.86018365 |
| 56 | UHMK1 | 0.85564374 |
| 57 | PTK2B | 0.85406128 |
| 58 | DMPK | 0.84972567 |
| 59 | OXSR1 | 0.83217308 |
| 60 | BMPR2 | 0.81958555 |
| 61 | MAPK13 | 0.80794862 |
| 62 | CSNK1G3 | 0.79519178 |
| 63 | MAP3K13 | 0.78543344 |
| 64 | FER | 0.78324075 |
| 65 | PDPK1 | 0.77719495 |
| 66 | CAMK2G | 0.77691751 |
| 67 | TTN | 0.77077246 |
| 68 | CDK14 | 0.77060116 |
| 69 | WNK4 | 0.75676046 |
| 70 | MARK2 | 0.75433212 |
| 71 | DDR2 | 0.74340816 |
| 72 | CDK15 | 0.73315638 |
| 73 | MYLK | 0.73233059 |
| 74 | PTK2 | 0.72816776 |
| 75 | ARAF | 0.71828852 |
| 76 | CAMK2A | 0.71540674 |
| 77 | ROCK2 | 0.71483570 |
| 78 | MAP2K1 | 0.71288657 |
| 79 | CDK18 | 0.70430006 |
| 80 | BMX | 0.70244608 |
| 81 | PDK1 | 0.66972148 |
| 82 | CSNK1G2 | 0.66757844 |
| 83 | PKN1 | 0.65423344 |
| 84 | CCNB1 | 0.64623168 |
| 85 | PRKCZ | 0.64568658 |
| 86 | CDC42BPA | 0.62280853 |
| 87 | DAPK3 | 0.62010746 |
| 88 | CDK11A | 0.60739035 |
| 89 | CSNK1G1 | 0.60563615 |
| 90 | CSNK1A1L | 0.60062766 |
| 91 | SGK1 | 0.59139436 |
| 92 | CAMK1G | 0.59043018 |
| 93 | PRKG2 | 0.58553472 |
| 94 | PTK6 | 0.57856891 |
| 95 | SGK3 | 0.57285095 |
| 96 | SGK223 | 0.56961938 |
| 97 | SGK494 | 0.56961938 |
| 98 | RPS6KA2 | 0.56904141 |
| 99 | MOS | 0.56614258 |
| 100 | WNK3 | 0.56564700 |
| 101 | PINK1 | 0.55035322 |
| 102 | FES | 0.54397133 |
| 103 | NEK1 | 0.53726927 |
| 104 | EIF2AK3 | 0.53104382 |
| 105 | FYN | 0.51829893 |
| 106 | CAMK2B | 0.51577886 |
| 107 | IRAK3 | 0.51300054 |
| 108 | MAP3K7 | 0.50814234 |
| 109 | ERBB4 | 0.50522957 |
| 110 | MAPK12 | 0.50460492 |
| 111 | EPHB2 | 0.50039538 |
| 112 | CAMK1 | 0.49580276 |
| 113 | FGFR3 | 0.49459551 |
| 114 | PRKCE | 0.49031866 |
| 115 | HIPK2 | 0.48801705 |
| 116 | ERBB3 | 0.48601896 |
| 117 | LIMK1 | 0.47891842 |
| 118 | IRAK2 | 0.46944216 |
| 119 | PRKCI | 0.46654045 |
| 120 | AKT3 | 0.45849359 |
| 121 | ROCK1 | 0.44606534 |
| 122 | FRK | 0.43724445 |
| 123 | RPS6KA3 | 0.43346827 |
| 124 | TRPM7 | 0.43297074 |
| 125 | ICK | 0.41932115 |
| 126 | SGK2 | 0.41525599 |
| 127 | RAF1 | 0.40116755 |
| 128 | PDGFRB | 0.39886346 |
| 129 | FGR | 0.39233151 |
| 130 | GRK1 | 0.39119098 |
| 131 | MST1R | 0.39091328 |
| 132 | TNIK | 0.38186842 |
| 133 | PRPF4B | 0.38170998 |
| 134 | BRSK1 | 0.37822783 |
| 135 | OBSCN | 0.37612621 |
| 136 | MAPKAPK5 | 0.37212611 |
| 137 | DYRK1A | 0.36951493 |
| 138 | WNK1 | 0.36512898 |
| 139 | PAK4 | 0.35920524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.01657216 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71731268 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26157497 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04475246 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.03499335 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01505914 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.00153802 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.94542646 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.90278279 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 1.85993983 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80333937 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.80020150 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74727715 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.70991397 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70691917 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67508283 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65095495 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.64717168 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60939352 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59117080 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57287983 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54951975 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.49671603 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.43956763 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42326026 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41612725 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37600579 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35669513 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30135502 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.29839798 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.26859915 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25564193 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.23844838 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22675866 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20720804 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.17777237 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16239976 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13895820 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.09874051 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07943304 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.06320774 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05564136 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04600435 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03514416 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01524167 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99325722 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98502385 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97842182 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97796058 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95323648 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94405200 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93697762 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92361904 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.92013610 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.91229267 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90350019 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.90149987 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89031940 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87595447 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86579689 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84328847 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83659020 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81857085 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81715842 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78878254 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78536884 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75042136 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74181449 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73977985 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73441162 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72205535 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70422894 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69864194 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67888875 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.67206063 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64804707 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64714412 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63735116 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63418452 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.62430432 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61964955 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59968072 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59875490 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59713949 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58661202 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.58081273 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57943093 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57913807 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56779857 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56729773 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56706211 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.56361149 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56241649 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55477057 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55442053 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.54833316 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53173558 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52694746 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.52499399 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52228800 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51277702 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50200832 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49504433 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49500070 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.47708719 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47415299 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46682281 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46516015 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46293496 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45936043 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45072044 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44662729 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44279607 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43263158 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42656063 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42655500 |
| 117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42012505 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41419372 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.41285432 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40710717 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40630887 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40516038 |
| 123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38708246 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38670783 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37956083 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37469304 |
| 127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36797949 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36688308 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35709532 |

